Victrex plc (LON:VCT) insider Timothy (Tim) J. Cooper sold 1,807 shares of the stock in a transaction that occurred on Friday, December 14th. The stock was sold at an average price of GBX 2,228 ($29.11), for a total value of £40,259.96 ($52,606.77).
Shares of VCT traded down GBX 16 ($0.21) during trading hours on Friday, hitting GBX 2,382 ($31.13). The stock had a trading volume of 219,258 shares, compared to its average volume of 274,177. Victrex plc has a 12-month low of GBX 1,826 ($23.86) and a 12-month high of GBX 2,772 ($36.22).
The business also recently declared a dividend, which will be paid on Friday, February 22nd. Stockholders of record on Thursday, January 31st will be given a GBX 128.82 ($1.68) dividend. This represents a dividend yield of 5.46%. The ex-dividend date is Thursday, January 31st. This is a positive change from Victrex’s previous dividend of $13.42.
A number of equities research analysts recently weighed in on VCT shares. UBS Group restated a “buy” rating and issued a GBX 3,200 ($41.81) price target (down previously from GBX 3,600 ($47.04)) on shares of Victrex in a report on Thursday, December 6th. Morgan Stanley cut Victrex to an “underweight” rating and lowered their target price for the company from GBX 2,500 ($32.67) to GBX 2,300 ($30.05) in a report on Friday, October 12th. HSBC reiterated a “hold” rating on shares of Victrex in a report on Tuesday. Liberum Capital reiterated a “buy” rating on shares of Victrex in a report on Tuesday, October 16th. Finally, Peel Hunt reiterated an “add” rating on shares of Victrex in a report on Friday, January 4th. Three investment analysts have rated the stock with a sell rating, six have issued a hold rating and three have assigned a buy rating to the company. Victrex currently has a consensus rating of “Hold” and a consensus price target of GBX 2,665.56 ($34.83).
Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. It operates through two segments, Victrex Polymer Solutions and Invibio Biomaterial Solutions. The company offers VICTREX PEEK polymer materials; and biomaterial solutions for use in spine, dental, trauma, knee, cardiovascular, and orthopedic applications.
Further Reading: Tariff